Louisiana 2022 Regular Session

Louisiana Senate Bill SB407

Introduced
3/29/22  
Introduced
3/29/22  
Refer
4/4/22  
Refer
4/4/22  
Report Pass
4/11/22  
Report Pass
4/11/22  
Engrossed
4/18/22  
Engrossed
4/18/22  
Refer
4/19/22  
Refer
4/19/22  
Report Pass
5/11/22  
Enrolled
6/1/22  
Chaptered
6/10/22  
Chaptered
6/10/22  

Caption

Requires schools to store epinephrine in the classrooms of certain students. (gov sig)

Impact

The implementation of SB 407 will significantly enhance state laws regarding the management of allergies and emergency medical response in schools. By institutionalizing the storage and administration of epinephrine, the bill addresses public health concerns related to allergic reactions, particularly in vulnerable student populations. This act is expected to standardize safety protocols across schools, thereby facilitating a quicker response to allergic emergencies which, if left unaddressed, can lead to severe health consequences.

Summary

Senate Bill 407 mandates that public elementary and secondary schools in Louisiana adopt policies to store auto-injectable epinephrine in classrooms for students at high risk of anaphylactic reactions who cannot self-administer the medication. The bill stipulates that schools must secure a supply of these medications and requires documentation from parents, including annual supply provision, authorization for administration, and a treatment plan from a licensed medical professional. This legislation is aimed at improving the response mechanisms for anaphylactic incidents within educational settings, fostering a safer environment for affected students.

Sentiment

Generally, the sentiment surrounding SB 407 has been positive among parents, educators, and health advocates, who view the legislation as a necessary step towards safeguarding student health. There has been an acknowledgment of the need to equip schools with the tools necessary to manage unexpected health crises effectively. Supporters argue that the legislation reflects a proactive approach to ensuring student safety and health awareness within the school environment.

Contention

Despite its supportive sentiment, some contention exists regarding the potential liability implications for schools and teachers associated with administering the medication. The bill contains provisions that protect schools from liability when epinephrine is administered in good faith, but concerns remain about how the policy will be operationalized. Additionally, there may be debates about the adequacy of training provided to teachers and staff to handle such medical emergencies, which could form a basis for future scrutiny and discussions as the bill is enacted.

Companion Bills

No companion bills found.

Previously Filed As

LA SB119

Provides for administration of auto-injectable epinephrine by a school nurse or trained school employee. (gov sig)

LA HB417

Authorizes early learning centers to maintain a supply of auto-injectable epinephrine

LA HB134

School districts; require all schools to have epinephrine auto-injectors in every building and cafeteria.

LA HB55

School districts; require all schools to have epinephrine auto-injectors in every building and cafeteria.

LA HB251

School districts; require all schools to have epinephrine auto-injectors in every building and cafeteria.

LA HB339

School districts; require all schools to have epinephrine auto-injectors in every building and cafeteria.

LA HB540

Requires public school governing authorities to provide for availability of and training with respect to the administration of certain medications to students (OR INCREASE LF EX See Note)

LA SB331

Schools; creating the Emerson Kate Cole Act; requiring a school employee to call 911 if Epinephrine is administered to a student; requiring certain training. Effective date. Emergency.

LA HB1166

To Clarify The Types Of Epinephrine For Use In Elementary And Secondary Schools In This State.

LA HF2489

Epinephrine access in schools requirements modified.

Similar Bills

No similar bills found.